Corriere Lucchese - Feed

Elsa Hosk Becomes the Face of Popular Haircare Brand Lunesi

Immediapress — Thu, 30 Jul 2026 10:01:06 +0200

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE

LONDON, July 30, 2026 /PRNewswire/ — Premium luxury haircare brand Lunesi announces Elsa Hosk as its new global brand ambassador, marking the beginning of an exciting new chapter for one of beauty’s fastest-growing premium brands.

Following its successful collaboration with Candice Swanepoel, Lunesi continues to strengthen its position in the luxury beauty market with one of the industry’s most recognised international fashion personalities.

Founded with the belief that exceptional hair begins with exceptional formulations, Lunesi has quickly earned recognition for its uncompromising approach to product development. Every formula is created using high-performance active ingredients at effective concentrations, combining cutting-edge cosmetic science with a luxurious sensory experience.

Designed for consumers who expect visible results without compromise, Lunesi collection focuses on restoring hair health, preventing damage and delivering lasting shine, strength and softness. Every product reflects the brand’s philosophy that true luxury lies not only in beautiful packaging, but in extraordinary performance.

Known for her effortless elegance and timeless beauty, Elsa Hosk perfectly embodies Lunesi’s vision of modern luxury—where sophistication, confidence and quality come together. Her partnership with the brand represents a natural evolution as Lunesi continues its international expansion.

With a growing global community and a commitment to innovation, Lunesi is redefining what luxury haircare means for a new generation—where science, performance and elevated beauty exist in perfect balance.

About Lunesi

Lunesi is a premium haircare brand dedicated to creating high-performance products using advanced technologies and carefully selected active ingredients. Every formula is developed to deliver professional-level results while offering a refined, luxurious experience. Designed for those who seek uncompromising quality, Lunesi combines innovation, efficacy and timeless elegance to transform everyday haircare into a true exceptional ritual.

www.lunesi.co.uk

Contact: lunesi@blacksquarepr.fr

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/elsa-hosk-becomes-the-face-of-popular-haircare-brand-lunesi-302838301.html

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire

Netcore is now Netcore.ai, becoming the first agentic marketing platform to share accountability for customer growth

Immediapress — Thu, 30 Jul 2026 10:01:04 +0200

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE

The rebrand signals a structural shift: from software vendor to AI-native outcome partner, backed by seven autonomous agents and a human co-ownership model

LONDON, July 30, 2026 /PRNewswire/ — Netcore Cloud, a global leader in MarTech, Customer Engagement, CPaaS, Email Marketing & Product discovery, today announced its rebrand to Netcore.ai, marking the company’s formal transition to an agentic marketing platform. The new identity reflects a fundamental change in how Netcore operates: its seven AI agents now autonomously plan, execute, analyse, and optimise marketing campaigns across the full customer lifecycle, while Netcore’s MarTech growth engineers remain co-accountable for each client’s growth outcomes. Netcore.ai is the first platform in the industry to move beyond software delivery into shared outcome ownership, a model where the vendor’s success is structurally tied to the client’s.

The announcement marks a structural shift in how enterprise marketing technology is sold and delivered. Where most platforms stop at capability and configuration, Netcore’s model assigns dedicated teams who share responsibility for campaign outcomes, activation results, and revenue contribution.

A unified stack for the entire customer journey, agents learning from each interaction

Netcore’s now powering the entire customer journey from intent to maximizing CLTV. Netcore’s agentic marketing platform brings together customer engagement, product discovery, personalisation, CDP, email marketing, and CPaaS channels into a single stack. All signals from these capabilities flow into a central context layer and governance layer, which builds a unified, consent-managed view of each customer and their journey in real time.

This unified architecture is the foundation on which Netcore’s seven AI agents operate. The agents autonomously plan, execute, analyse, and optimise hyper-personalised marketing campaigns across every channel and every stage of the customer lifecycle. Because every agent draws from the same contextual layer, decisions made in one channel are immediately available across all others.

Humans and agents, working as one team

Autonomous execution does not mean unsupported execution. Each client is paired with an experienced Netcore growth engineer who monitors performance, interprets signals, and intervenes where judgement matters. The agents handle the volume and velocity that no human team can sustain. The growth engineers bring deep domain expertise and proven industry playbooks to help customers achieve and outperform industry benchmarks.

“Most platforms hand you the keys and step back,” said Rajesh Jain, Founder & MD at Netcore. “We designed this differently. The agents run the campaigns. Our teams stay in the room. And we carry the same accountability for outcomes that our clients do.”

Outcome based pricing

Netcore’s co-ownership model formalises what has historically been left to goodwill in vendor relationships. Under this model, Netcore does not simply deliver software and measure usage. The company structures its engagement around the client’s business KPIs, with its teams directly accountable for the outcomes the platform was deployed to achieve.

This means clients gain two things simultaneously: the execution speed of AI agents that operate across millions of customer touchpoints without manual intervention, and the strategic continuity of a dedicated team that is financially and operationally invested in making the numbers move.

The model is designed specifically for marketing organisations that face growing pressure to demonstrate revenue contribution from their technology investments, not just platform adoption.

The agentic marketing platform is available now across Netcore’s markets in India, Southeast Asia, the Middle East, North America, Europe and Africa. Enterprise clients can access the full platform, including the unified Context Layer and all seven AI agents, through Netcore’s existing engagement structure.

About Netcore

Netcore, a leading agentic marketing platform, leverages its comprehensive Customer Engagement Suite to create personalised, omnichannel experiences. Trusted by over 6,500 brands across sectors like Ecommerce, Retail, Banking and Financial Services, Media and Entertainment, and Travel, its marquee clients include Walmart, Unilever, Tommy Hilfiger, Domino’s, McDonald’s, Pizza Hut, and Crocs. Netcore is appraised at Level 3 of ISACA’s CMMI® by Equalitas Certifications Limited, reaffirming its commitment to process excellence. For more information, visit netcore.ai Our website summary is – https://netcore.ai/about-us/

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/netcore-is-now-netcoreai-becoming-the-first-agentic-marketing-platform-to-share-accountability-for-customer-growth-302837866.html

—

immediapress/pr-newswire

Starlight Investments Completes First Phase of The Parklands, a Major New 231-Suite Rental Community in Dartford

Immediapress — Thu, 30 Jul 2026 09:02:51 +0200

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE

Initial phase brings 58 new rental homes to market as development progresses on master-planned build-to-rent community

DARTFORD, United Kingdom, July 30, 2026 /PRNewswire/ — Starlight Investments (“Starlight”), a leading global real estate investment and asset management firm, has announced the completion and launch of the first phase of The Parklands, a new master-planned build-to-rent community in Dartford, Kent.

The milestone marks the delivery of the community’s first 58 rental homes across two residential buildings and the latest step in bringing a major new rental community to one of the most well-connected and rapidly growing markets within London’s commuter belt.

The newly completed residences offer a mix of high-quality studio, one-, two- and three-bedroom homes featuring modern finishes and layouts suited to a range of lifestyles and life stages.

Upon full completion, The Parklands will feature 231 suites across seven residential buildings. The development will help address growing demand for rental housing while broadening housing choice for residents seeking homes in a highly connected location.

As future phases are completed, residents will gain access to a range of exceptional amenities designed to enhance convenience, well-being and community living. Planned amenities include a residents’ lounge, fitness centre, yoga studio, co-working space and a 2,000-square-foot rooftop terrace. The completed community will also provide 163 resident parking spaces.

“The completion of the first phase at The Parklands reflects our continued commitment to delivering high-quality rental housing in communities where demand continues to grow,” said Jonnie Milich, Head of UK Residential, Starlight Investments. “The Parklands is an important addition to Dartford’s housing landscape, bringing new rental homes to market as part of a thoughtfully designed community that will continue to evolve as future phases are completed. We are pleased to welcome our first residents and look forward to continuing to bring this community to life.”

The Parklands offers residents convenient access to Central London and key employment centres through strong road and rail connections, with close proximity to Dartford Station. Positioned alongside Central Park, the community also provides residents with access to expansive green space and recreational amenities that enhance quality of life.

The development’s location adjacent to Central Park is reflected in the name “The Parklands,” with a visual identity inspired by the intersection of nature and urban living, blending natural elements with a modern design aesthetic.

The completion of the initial phase at The Parklands marks another step in Starlight’s continued growth in the UK and commitment to delivering new rental housing in high-growth markets across the region. Starlight’s UK residential platform comprises approximately 4,000 homes and £1.1 billion in assets under management.

Learn more: https://www.theparklands-dartford.co.uk

About Starlight Investments

Starlight Investments is a leading global real estate investment and asset management firm headquartered in Toronto, Ontario, Canada. A privately held owner, developer and asset manager of over 70,000 multi-residential suites and over 7 million square feet of commercial property space with CAD $30 billion AUM, Starlight offers a range of investment vehicles across various real estate strategies. Starlight’s guiding mission is to balance its tenure with visionary curiosity to create positive impact for investors and communities alike. At Starlight, we invest with impact.

Learn more at www.starlightinvest.com or connect with us on LinkedIn.

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/starlight-investments-completes-first-phase-of-the-parklands-a-major-new-231-suite-rental-community-in-dartford-302838547.html

—

immediapress/pr-newswire

Destinus selected among the five highest-ranked applicants in the European Defence Agency’s Sentinel Strike Challenge

Immediapress — Thu, 30 Jul 2026 09:00:48 +0200

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE

Following Stage 1 evaluation, Destinus has been invited to demonstrate its system in EDA’s operational experimentation campaign in Portugal this autumn.

BRUSSELS, July 30, 2026 /PRNewswire/ — Destinus, a European developer and manufacturer of strike missile systems and interceptor systems, has been ranked among the five highest-scoring applicants in Stage 1 of the European Defence Agency’s Prize Contest “Sentinel Strike Challenge” on loitering munitions, run through EDA’s Hub for European Defence Innovation (HEDI). As a Stage 1 winner, Destinus is invited to Stage 2 of the contest: an operational experimentation campaign hosted by the Portuguese Army at the Santa Margarida Military Training Area.

The Sentinel Strike Challenge supports the operational experimentation of emerging loitering munition capabilities in Europe. It is designed to generate comparable operational evidence on the performance, resilience, reliability, safety and operational suitability of complete systems, assessed across the full precision strike mission cycle — from mission planning and launch through target detection, engagement and post-strike assessment — in realistic, degraded and contested conditions. Stage 2 takes place within EDA’s Operational Experimentation Campaign 2026 (OPEX26 PT), conducted in conjunction with the Portuguese Army’s ARTEX26 experimentation exercise, from 28 September to 9 October 2026.

Destinus will demonstrate a complete loitering munition system developed and produced in Europe with operational experience in demanding environments. The selection follows an evaluation of technical proposals submitted by applicants from across participating EU Member States.

Stage 2 results will be announced at the EDA Annual Conference in early 2027.

Contact: destinus@fticonsulting.com

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/destinus-selected-among-the-five-highest-ranked-applicants-in-the-european-defence-agencys-sentinel-strike-challenge-302838345.html

—

immediapress/pr-newswire

Milliken Begins Commercial Production of Millad ClearX™ 9000 to Support Growing Demand for Advanced Polypropylene Solutions

Immediapress — Thu, 30 Jul 2026 08:01:33 +0200

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE

MUMBAI, India, July 30, 2026 /PRNewswire/ — Milliken & Company today announced the successful startup of dedicated production capacity for Millad ClearX™ 9000, the company’s fifth-generation clarifier technology designed to deliver exceptional clarity, performance, and processing efficiency in polypropylene applications. The new manufacturing capability strengthens Milliken’s ability to support customers with reliable supply, consistent quality, and continued innovation as demand for advanced polypropylene solutions grows wordwide.

“The strong market response to Millad ClearX™ 9000 validates the value this technology delivers for polypropylene manufacturers,” said Wim Van De Velde, EVP and managing director for Milliken’s plastic additives business. “Dedicated capacity strengthens our ability to support customers with reliable supply while providing the flexibility needed to support continued adoption of the technology.”

The new manufacturing capability marks an important milestone in Milliken’s ongoing commitment to operational excellence and customer support. Dedicated production capacity strengthens the resilience of the company’s global manufacturing network, complements its existing operations, increases flexibility to respond to changing market requirements, and helps ensure consistent product availability. The investment enhances Milliken’s ability to meet evolving customer needs while supporting the industry’s transition to next-generation clarifier technology.

“Millad ClearX™ 9000 helps manufacturers raise the performance and visual appeal of polypropylene products without compromising manufacturing productivity,” said Allan Randall, global product line manager for Milliken’s plastic additives business. “Customers are looking for ways to improve product appearance and performance while maintaining production efficiency. ClearX 9000 helps them do both.”

Millad ClearX™ 9000 represents the latest advancement in Milliken’s industry-leading clarifier portfolio. Developed to enhance polypropylene transparency and aesthetics, the technology helps manufacturers create high-performing products for consumer, packaging, and industrial applications. To learn more about Milliken’s plastic additives portfolio, visit milliken.com.

About Milliken Milliken harnesses materials science to deliver tomorrow’s breakthroughs today. Discover our innovative portfolio of textiles, flooring, specialty chemicals, and healthcare solutions at milliken.com and on Facebook, Instagram, and LinkedIn.

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/milliken-begins-commercial-production-of-millad-clearx-9000-to-support-growing-demand-for-advanced-polypropylene-solutions-302838605.html

—

immediapress/pr-newswire

METLEN firma un accordo storico per la fornitura di gallio

Immediapress — Thu, 30 Jul 2026 05:27:57 +0200

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE

IL PRESENTE COMUNICATO CONTIENE INFORMAZIONI PRIVILEGIATE AI SENSI DELL’ARTICOLO 7 DEL REGOLAMENTO SUGLI ABUSI DI MERCATO (UE) 596/2014 (“EU MAR”) E DELL’ARTICOLO 7 DEL REGOLAMENTO SUGLI ABUSI DI MERCATO (UE) 596/2014 IN QUANTO FORMA PARTE DEL DIRITTO NAZIONALE NEL REGNO UNITO (IL “REGNO UNITO”) IN VIRTÙ DELL’EUROPEAN UNION (WITHDRAWAL) ACT 2018 (“UK MAR”)

Una tappa fondamentale per la strategia europea sulle materie prime critiche

ATENE e LONDRA, 30 luglio 2026 /PRNewswire/ — METLEN annuncia un accordo commerciale a lungo termine per la fornitura di circa il 25% della produzione annuale di gallio proveniente dal proprio impianto di produzione in fase di realizzazione in Grecia. I termini dell’accordo sono riservati.

L’accordo rappresenta il primo importante accordo commerciale per la fornitura di gallio tra un produttore europeo e un’azienda tecnologica statunitense di primo piano, e costituisce una pietra miliare strategica per gli sforzi dell’Europa volti a rafforzare la resilienza della propria catena di approvvigionamento delle materie prime critiche.

Il gallio è una materia prima fondamentale, essenziale per la tecnologia dell’IA, le infrastrutture avanzate nel settore delle energie rinnovabili, le telecomunicazioni e le soluzioni per la difesa. Oggi la produzione mondiale di gallio è concentrata in misura preponderante, rendendo lo sviluppo di fonti di approvvigionamento alternative e affidabili di importanza strategica per tutte le economie industriali.

METLEN è la prima azienda in Europa ad aver avviato una produzione integrata di gallio e la prima ad aver stipulato un accordo commerciale per il gallio prodotto in Europa, ponendo la Grecia e l’Europa all’avanguardia di una nuova catena del valore industriale strategica.

Questo risultato è frutto del lungo impegno nel campo della ricerca e dell’innovazione dei team interni di ricerca e sviluppo dell’azienda, con sede nello storico stabilimento industriale di Aluminium of Greece, insieme al sottosettore Critical & Rare Metals di M Metals, di recente costituzione.

Evangelos Mytilineos, presidente esecutivo di METLEN, ha commentato così l’accordo: “Siamo particolarmente orgogliosi che METLEN stia aprendo un nuovo capitolo nella storia industriale sia della Grecia che dell’Europa; lo sviluppo della produzione di gallio realizzato con successo dai nostri team presso Aluminium of Greece. Per la prima volta nella storia di METLEN, uno dei nostri prodotti metallurgici ha suscitato un interesse così forte da parte delle principali economie industriali di tutto il mondo. Ciò riflette sia l’importanza strategica del gallio sia la fiducia riposta dai leader tecnologici mondiali nella qualità e nell’affidabilità del nostro materiale, che è già stato sottoposto a approfonditi test di qualificazione”.

L’investimento di punta di METLEN per la produzione di gallio è stato ufficialmente riconosciuto dalla Commissione europea come progetto strategico ai sensi del Critical Raw Materials Act (CRMA). L’importanza strategica del progetto è stata riconosciuta anche dalla Banca europea per gli investimenti (BEI), che ha approvato un finanziamento nell’ambito del programma REPowerEU.

Informazioni su METLEN

METLEN Energy & Metals Plc (METLEN) è una società industriale ed energetica internazionale che occupa una posizione di leadership nei settori metallurgico ed energetico, incentrata sulla crescita sostenibile e sull’economia circolare. METLEN si è affermata come punto di riferimento nell’ambito della metallurgia “verde” competitiva a livello europeo e mondiale, in quanto gestisce l’unico impianto completamente integrato per la produzione di bauxite, allumina e alluminio primario nell’Unione Europea, con strutture portuali di proprietà privata. Nel settore energetico, METLEN offre soluzioni energetiche integrate attraverso la realizzazione di progetti di produzione di energia termica e rinnovabile, la distribuzione e la fornitura di energia elettrica, nonché investimenti in infrastrutture di rete, sistemi di accumulo a batteria e altre tecnologie verdi. METLEN opera in cinque continenti e in più di 40 Paesi, impiegando oltre 8.500 dipendenti in tutto il mondo e implementando un modello pienamente sinergico in tutti i suoi settori.

Dati finanziari chiave di METLEN

METLEN è quotata principalmente alla Borsa di Londra e secondariamente alla Borsa di Atene, ed è inclusa nell’indice FTSE 100. Nel 2025, METLEN ha registrato un fatturato consolidato di 7,11 miliardi di euro e un EBITDA di 753 milioni di euro, con un utile netto di 314 milioni di euro. La posizione finanziaria netta rettificata si è attestata a 2,10 miliardi di euro, con un rapporto indebitamento netto/EBITDA di 3,1x, a testimonianza di una forte resilienza finanziaria. METLEN è valutata dalle principali agenzie internazionali di sostenibilità ed ESG, occupando una posizione di rilievo in Grecia nell’indice Dow Jones Best-in-Class Emerging Market e distinguendosi nei rating di MSCI, Sustainalytics, ISS Quality score, ISS Corporate Score, S&P Global ESG, LSEG, CDP, FTSE Russell, ESG Book, EcoVadis, Bloomberg e IdealRatings.

www.metlen.com | Facebook | X | YouTube | LinkedIn

Avvisi importanti

La persona responsabile della diffusione del presente comunicato per conto di Metlen Energy & Metals PLC è Leda Condoyanni, segretaria aziendale.

Numero LEI: 213800ZSR3HVKMMPVG86

Il presente comunicato contiene informazioni privilegiate ai sensi dei regolamenti sugli abusi di mercato di UE (EU MAR) e Regno Unito (UK MAR).

Il presente comunicato contiene dichiarazioni che sono o possono essere considerate “dichiarazioni previsionali”. Le dichiarazioni previsionali comportano rischi e incertezze perché si riferiscono a eventi e dipendono da eventi o circostanze che potrebbero verificarsi o meno in futuro. Tutte le dichiarazioni previsionali contenute nel presente comunicato riflettono la visione attuale di METLEN in merito a eventi futuri alla data del presente comunicato. Le dichiarazioni previsionali non costituiscono una garanzia di risultati futuri e i risultati effettivi nei periodi futuri potrebbero differire, e spesso differiscono in modo sostanziale da quelli espressi in tali dichiarazioni. Salvo ove richiesto da leggi o regolamenti, METLEN non si assume alcun obbligo di rendere pubblici i risultati di eventuali revisioni delle dichiarazioni previsionali contenute nel presente comunicato che possano verificarsi in seguito a cambiamenti nelle proprie aspettative, o al fine di riflettere eventi o circostanze insorti dopo la data del presente comunicato.

View original content to download multimedia:https://www.prnewswire.com/it/comunicati-stampa/metlen-firma-un-accordo-storico-per-la-fornitura-di-gallio-302838522.html

—

immediapress/pr-newswire

Muore annegato dopo un tuffo nelle acque del torrente Lima

REDAZIONE — Wed, 29 Jul 2026 20:49:41 +0200

BAGNI DI LUCCA – Tragedia nelle acque del torrente Lima, nel territorio comunale di Bagni di Lucca, dove un giovane di 27 anni ha perso la vita a causa di un annegamento durante una gita fuori porta. La vittima è un ragazzo di origine peruviana residente a Firenze.

L’allarme e la macchina dei soccorsi sono scattati nel primo pomeriggio, intorno alle 14, in località Ponte a Maggio. Secondo quanto ricostruito finora dalle prime testimonianze, il ventisettenne si trovava in fiume insieme a due amici per fare un bagno e rinfrescarsi. Il giovane si trovava a bordo di un materassino gonfiabile quando, per cause ancora in corso di accertamento, il natante si è improvvisamente ribaltato. Finito in acqua, il ragazzo è sprofondato senza più riuscire a riemergere in superficie.

L’immediata chiamata d’emergenza ha fatto convergere sul posto i sanitari del 118, le squadre dei vigili del fuoco, comprese le unità dei sommozzatori e le squadre del Soccorso Alpino. Proprio questi ultimi, dopo accurate ricerche nello specchio d’acqua, hanno individuato e recuperato il corpo ormai privo di vita del ventisettenne.

La vittima era giunta nella frazione del comune lucchese da Firenze per trascorrere una giornata di relax insieme a un piccolo gruppo di amici.

REDAZIONE

/DISREGARD RELEASE: Fractus/

Immediapress — Wed, 29 Jul 2026 19:27:45 +0200

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE

We are advised by Fractus that journalists and other readers should disregard the news release, Fractus and Geotab settle U.S. patent litigation, issued 27-Jul-2026 over PR Newswire.

—

immediapress/pr-newswire

TCMA Launches “The NEXT Chapter” with 5 Engines to Accelerate Cement Industry Toward Net Zero 2050

Immediapress — Wed, 29 Jul 2026 18:10:09 +0200

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE

Thai Cement Manufacturers Association (TCMA) has advanced its strategy, “The NEXT Chapter to Net Zero 2050,” through five key implementation pillars – “5 Engines to Net Zero” – under the theme ‘Accelerating Collaborative Action towards Net Zero 2050.’ The initiative aims to accelerate the transition of Thailand’s cement industry toward a low-carbon future, while elevating its role as a Climate Solution Partner, in alignment with Thailand 2050 Net Zero Cement and Concrete Roadmap, a shared industry commitment.

BANGKOK, THAILAND –
Media OutReach Newswire
– 29 July 2026 – Amid growing climate pressures and intensifying global competition, Thailand’s cement industry is accelerating its transformation by integrating policy, technology, innovation, energy transition, circular economy, and digitalization into practical implementation; enhancing competitiveness while reducing greenhouse gas emissions.

Mr. Surachai Nimla-or, Chairman of TCMA, stated that “The NEXT Chapter” represents a critical inflection point for the industry, guided by the principle of being “competitive, growth-oriented, and low-carbon.” TCMA is advancing this transition through five key engines:

“The core of ‘The NEXT Chapter’ is ‘accelerating collaborative action’; connecting policy, technology, and investment to deliver measurable and scalable impact,” said Mr. Surachai. He added that TCMA continues to advance SARABURI SANDBOX, a low-carbon city pilot that serves as a testing ground for innovative technologies and mechanisms before scaling at the national and regional levels.

The implementation of the 5 Engines to Net Zero reflects the industry’s transition from a traditional producer to a solution provider in addressing climate change, reinforcing the role of Thailand’s cement industry as a key driver in the country’s pathway toward Net Zero 2050.

Hashtag: #TCMA #TCMAat20 #TCMAinAction #TCMAtoNetZero2050 #NextChapterNetZero

#ClimateSolutionPartner #CementDecarbonization

The issuer is solely responsible for the content of this announcement.

Contatti:
Immediapress
comunicati@immediapress.it

Media OutReach Newswire

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE

Responsabilità editoriale di Immediapress

—

immediapress

PR Newswire Expands AEO & GEO Brand Report to Europe, the Middle East, India and Africa

Immediapress — Wed, 29 Jul 2026 16:54:00 +0200

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE

Brand-level AI visibility intelligence empowers PR, marketing and investor relations teams to actively command their brand presence across the generative search landscape with a single end-to-end amplification platform.

LONDON, July 29, 2026 /PRNewswire/ — AI-powered search and generative answer engines are rapidly reshaping how audiences discover and evaluate brands. As a result, communicators are increasingly seeking data-driven insights into their organisation’s presence within this evolving landscape. To help global communicators move beyond traditional SEO metrics and take their brand’s AI visibility to the next level, PR Newswire is expanding availability of its AEO & GEO Brand Report to customers in Europe, the Middle East, India and Africa.

Experience the full interactive Multichannel News Release here: https://www.multivu.com/pr_newswire/9405751-en-gb-pr-newswire-expands-aeo-geo-brand-report-to-emeia

The report, integrated into the PR Newswire Amplify™ platform, provides measurable insights into how AI models reference and position brands, helping customers not only understand their AI footprint but actively shape it through the world’s most trusted distribution network.

Strategic AI Search Insights for Communications Professionals

Powered by Trajaan, a Cision company, the new report captures three distinct categories of data to provide a brand-level view of AI visibility:

“We are thrilled to bring this brand-level AI search intelligence to more customers around the world,” said PR Newswire President Matt Brown. “In an environment where AI models synthesise information from countless sources, the press release remains an authoritative foundation for any campaign. By expanding the availability of the AEO & GEO Brand Report, we’re providing a unique, end-to-end advantage for global brands operating across multiple regions: the ability to see how you are perceived by AI within these markets, and the trusted, multichannel tools to actively strengthen that position.”

Turn AI Insights into Smarter Content Strategy

Launching the new report natively within Amplify allows users to move instantly from identifying an AI visibility gap to closing it via targeted Multichannel Amplification™.

By leveraging PR Newswire’s PR-driven platform alongside Trajaan’s proprietary search intelligence data, communicators can bridge the gap between content creation and algorithmic recognition. The report insights help teams strengthen content planning and strategy, optimise messaging for answer engines and generative engines across multiple content types, and use multichannel distribution strategies that reinforce credibility signals through the world’s largest, most credible distribution network.

The wider availability of the report follows the recent expansion of multilingual campaign support within Amplify, making it the latest example of how PR Newswire is constantly innovating to help communicators around the world both stay ahead of the curve in a fast-moving AI search landscape and reach global audiences with on-brand content that resonates with target audiences.

To learn more about the new capability and other features available in the Amplify Report module, visit https://www.prnewswire.co.uk/amplify-report-module/.

About PR Newswire

PR Newswire is the industry’s leading press release distribution partner with an unparalleled global reach of more than 500,000 newsrooms, websites, direct feeds, journalists and influencers and is available in more than 170 countries and 40 languages. From our innovative AI-powered PR Newswire Amplify™ platform, award-winning Content Services offerings, integrated media newsroom and microsite products, Investor Relations suite of services, paid placement and social sharing tools, PR Newswire has a comprehensive Multichannel Amplification™ catalogue of solutions to solve the modern-day challenges PR and communications teams face. For more than 70 years, PR Newswire has been the preferred destination worldwide for brands to share their most important news stories.

About Cision

Cision is the global leader in consumer and media intelligence, engagement, and communication solutions. We equip PR and corporate communications, marketing, and social media professionals with the tools they need to excel in today’s data-driven world. Our deep expertise, exclusive data partnerships, and award-winning products, including CisionOne, Brandwatch, PR Newswire, and Trajaan, enable over 75,000 companies and organisations, including 84% of the Fortune 500, to see and be seen, understand and be understood by the audiences that matter most to them.

View original content:https://www.prnewswire.co.uk/news-releases/pr-newswire-expands-aeo–geo-brand-report-to-europe-the-middle-east-india-and-africa-302832581.html

—

immediapress

POSITIVE CHMP OPINION SUPPORTS BROADER USE OF AMGEN’S REPATHA® BEFORE A FIRST HEART ATTACK OR STROKE

Immediapress — Wed, 29 Jul 2026 15:02:50 +0200

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE

Repatha is the Only PCSK9 Inhibitor Proven to Significantly Reduce Risk of First Heart Attack and Stroke in Phase 3 Clinical Trial, Setting a New Benchmark in Cardiovascular Risk Reduction

Recommendation Based on the Landmark Phase 3 Global VESALIUS-Cardiovascular Trial of More Than 12,000 Patients

THOUSAND OAKS, Calif., July 29, 2026 /PRNewswire/ — Amgen (NASDAQ: AMGN) today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for Repatha® (evolocumab) for adults with established or at high risk for atherosclerotic cardiovascular disease to reduce cardiovascular risk by lowering LDL-C levels, as an adjunct to correction of other risk factors. The recommendation is based on results from the Phase 3 VESALIUS-CV trial, which demonstrated that Repatha significantly reduced the risk of major adverse cardiovascular events (MACE) in high-risk adults without a prior heart attack or stroke, when added to statins or other LDL-C-lowering treatments.

“There remains a significant unmet need in Europe, where many patients at high cardiovascular risk are unable to achieve recommended LDL-C levels despite available lipid-lowering therapies,” said Paul Burton, M.D., Ph.D., chief medical officer at Amgen. “The CHMP’s positive opinion reflects the strength of Repatha’s clinical evidence and brings us one step closer to making Repatha available to more patients who may benefit from it. Repatha is the only PCSK9 inhibitor proven in a Phase 3 clinical trial to reduce the risk of a first major cardiovascular event. If approved by the European Commission, this expanded indication has the potential to redefine cardiovascular care for appropriate patients in Europe.”

Cardiovascular disease is the leading cause of death worldwide.1 Recent research shows that more than 99% of people who experience a first-time cardiovascular event have at least one traditional risk factor, including high LDL-C, which is one of the most modifiable risk factors for heart attack or stroke.2 While the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) guidelines recommend intensive LDL-C lowering based on cardiovascular risk, many high-risk patients remain above recommended LDL-C targets despite available lipid-lowering therapies.3

Repatha was initially approved in the European Union in 2015 for the treatment of adults and pediatric patients with primary hypercholesterolemia or mixed dyslipidemia, as well as to reduce cardiovascular risk in adults with established ASCVD. The European Commission is expected to make a final decision on the application in the coming months.

About the VESALIUS-CV TrialVESALIUS-CV is a Phase 3, double-blind, randomized, placebo-controlled, global clinical trial designed to evaluate the impact of LDL-C lowering with evolocumab on MACE in adults at high CV risk without prior heart attack or stroke. Results were published in the New England Journal of Medicine in November 2025. Repatha demonstrated a 25% relative reduction in the risk of a composite of coronary heart disease (CHD) death, heart attack or ischemic stroke (3-P MACE), and 19% reduction in a broader composite that also included any ischemia-driven arterial revascularization (4-P MACE). Evolocumab also reduced the risk of heart attack by 36%. A consistent benefit was seen with evolocumab vs. placebo across all three endpoints, including the reduced risk of heart attack by 36%. In a lipid sub-study, adding evolocumab to a maximally tolerated dose of statin and/or ezetimibe substantially lowered LDL-C levels among observed patients, with a median level of 45 mg/dL compared to 109 mg/dL in the placebo group.

VESALIUS-CV enrolled more than 12,000 patients with known ASCVD or high-risk diabetes, who had no history of heart attack or stroke, an LDL-C ≥ 90 mg/dL, or non-high-density lipoprotein cholesterol (non-HDL-C) ≥ 120 mg/dL, or apolipoprotein B ≥ 80 mg/dL; and treated with highest tolerated dose of statin and/or ezetimibe. The median baseline LDL-C was 122 mg/dL (IQR, 104-149 mg/dL) on local lab testing. Participants were randomized to receive evolocumab or placebo in addition to optimized lipid-lowering therapy and were followed for a median of approximately 4.6 years.

Amgen’s Commitment to Cardiovascular InnovationAmgen is redefining cardiometabolic care with cutting-edge science rooted in human biology that addresses closely connected cardiovascular and metabolic diseases that lead to serious outcomes or death.

Cardiometabolic conditions commonly coexist and can lead to serious outcomes or death, even though they are treatable.4 Despite advances in lipid-lowering and metabolic therapies, substantial residual cardiovascular risk remains, driven by persistent LDL-C elevation, genetically mediated Lp(a) and obesity-related cardiometabolic dysfunction.5

Leveraging 40+ years of cutting-edge science and human genetics, Amgen is redefining cardiometabolic care and risk management. With years of success in cardiovascular disease with Repatha, Amgen is well positioned to deliver potential breakthrough medicines like MariTide and olpasiran to help address patient needs in cardiometabolic care and multiple interconnected drivers of cardiovascular and metabolic disease.

About RepathaRepatha is a human monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9). Repatha binds to PCSK9 and inhibits circulating PCSK9 from binding to the low-density lipoprotein (LDL) receptor (LDLR), preventing PCSK9-mediated LDLR degradation and permitting LDLR to recycle back to the liver cell surface. By inhibiting the binding of PCSK9 to LDLR, Repatha increases the number of LDLRs available to clear LDL from the blood, thereby lowering LDL-C levels.

Repatha is one of the most extensively studied PCSK9 inhibitors, with clinical and real-world evidence across diverse populations and CV risk profiles.6 The clinical benefits and safety of Repatha have been studied for 15 years in 51 clinical trials with over 57,000 patients.7 Repatha is the only PCSK9 inhibitor to demonstrate a significant reduction of cardiovascular events as both high-risk primary and secondary prevention, with patients achieving and maintaining dramatic LDL-C reductions using Repatha only once every two weeks.8,9

Repatha was first approved in 2015 and has since been used by more than 10 million patients globally.10 In August 2025, the U.S. Food and Drug Administration broadened the approved use of Repatha to include adults at increased risk for major adverse CV events due to uncontrolled LDL-C. Repatha is approved in 74 countries, including the U.S., Japan, Canada and in all 28 countries that are members of the European Union.11 Applications in other countries are pending.

Important EU Product Information

In Europe Repatha is approved for use in:

Hypercholesterolemia and mixed dyslipidemiaRepatha is indicated in adults with primary hypercholesterolemia (heterozygous familial and non-familial) or mixed dyslipidemia, as an adjunct to diet:

Homozygous familial hypercholesterolemiaRepatha is indicated in adults and adolescents aged 12 years and over with homozygous familial hypercholesterolemia in combination with other lipid-lowering therapies.

Atherosclerotic cardiovascular diseaseRepatha is indicated in adults with established or at high risk for atherosclerotic cardiovascular disease to reduce cardiovascular risk by lowering LDL‑C levels, as an adjunct to correction of other risk factors:

PosologyPrimary hypercholesterolemia and mixed dyslipidemia in adults

The recommended dose of Repatha is either 140 mg every two weeks or 420 mg once monthly; both doses are clinically equivalent.

Homozygous familial hypercholesterolemia in adults and adolescents aged 12 years and over

The initial recommended dose is 420 mg once monthly. After 12 weeks of treatment, dose frequency can be up-titrated to 420 mg once every 2 weeks if a clinically meaningful response is not achieved. Patients on apheresis may initiate treatment with 420 mg every two weeks to correspond with their apheresis schedule.

Important Safety InformationThis medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.

Contraindications: Hypersensitivity to the active substance or to any of the excipients.

Special Warnings and Precautions: Renal impairment: Patients with severe renal impairment (defined as eGFR < 30 mL/min/1.73 m2) have not been studied. Repatha should be used with caution in patients with severe renal impairment. Hepatic impairment: In patients with moderate hepatic impairment, a reduction in total evolocumab exposure was observed that may lead to a reduced effect on LDL‑C reduction. Therefore, close monitoring may be warranted in these patients. Patients with severe hepatic impairment (Child-Pugh C) have not been studied. Repatha should be used with caution in patients with severe hepatic impairment. Dry natural rubber: The needle cover of the glass pre-filled syringe and of the pre-filled pen is made from dry natural rubber (a derivative of latex), which may cause allergic reactions. Sodium content: Repatha contains less than 1 mmol sodium (23 mg) per dose, i.e. it is essentially 'sodium-free'.

Interactions: No formal drug-drug interaction studies have been conducted for Repatha. No studies on pharmacokinetic and pharmacodynamics interaction between Repatha and lipid-lowering drugs other than statins and ezetimibe have been conducted.

Fertility, Pregnancy and Lactation: There are no or limited amount of data from the use of Repatha in pregnant women. Repatha should not be used during pregnancy unless the clinical condition of the woman requires treatment with evolocumab. It is unknown whether evolocumab is excreted in human milk. A risk to breastfed newborns/infants cannot be excluded. No data on the effect of evolocumab on human fertility are available.

Undesirable Effects: The following common (> 1/100 to < 1/10) adverse reactions have been reported in pivotal, controlled clinical studies: influenza, nasopharyngitis, upper respiratory tract infection, rash, nausea, back pain, arthralgia, injection site reactions. Please consult the SmPC for a full description of undesirable effects.

Pharmaceutical Precautions: Store in a refrigerator (2 degrees C – 8 degrees C). Do not freeze. Keep the pre-filled syringe or the pre-filled pen in the original carton in order to protect from light. If removed from the refrigerator, Repatha may be stored at room temperature (up to 25 degrees C) in the original carton and must be used within 1 month.

US INDICATIONSRepatha® is a PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitor indicated:

The safety and effectiveness of Repatha® have not been established in pediatric patients with HeFH or HoFH who are younger than 10 years old or in pediatric patients with other types of hypercholesterolemia. For full prescribing information, visit www.Repatha.com.

IMPORTANT SAFETY INFORMATION

Please see full Prescribing Information.

About Amgen Amgen discovers, develops, manufactures and delivers innovative medicines to fight some of the world’s toughest diseases. Harnessing the best of biology and technology, Amgen reaches millions of patients with its medicines.

More than 45 years ago, Amgen helped establish the biotechnology industry at its U.S. headquarters in Thousand Oaks, California, and it remains at the cutting edge of innovation, using technology and human genetic data to push beyond what is known today. Amgen is advancing a broad and deep pipeline and portfolio of medicines to treat cancer, heart disease, inflammatory conditions, rare diseases and obesity and obesity-related conditions.

Amgen has been consistently recognized for innovation and workplace culture, including honors from Fast Company and Forbes. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average®, and it is also part of the Nasdaq-100 Index®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization.

For more information, visit Amgen.com and follow Amgen on X, LinkedIn, Instagram, YouTube, Facebook, TikTok and Threads.

Forward-Looking StatementsThis news release contains forward-looking statements that are based on the current expectations and beliefs of Amgen. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including any statements on the outcome, benefits and synergies of collaborations, or potential collaborations, with any other company (including BeOne Medicines Ltd. or Kyowa Kirin Co., Ltd.), the performance of Otezla® (apremilast), our acquisitions of ChemoCentryx, Inc., Dark Blue Therapeutics, Ltd. or Horizon Therapeutics plc (including the prospective performance and outlook of Horizon’s business, performance and opportunities, and any potential strategic benefits, synergies or opportunities expected as a result of such acquisition), as well as estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes, effects of pandemics or other widespread health problems on our business, outcomes, progress, and other such estimates and results. Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission reports filed by Amgen, including our most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and current reports on Form 8-K. Unless otherwise noted, Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.

No forward-looking statement can be guaranteed and actual results may differ materially from those we project. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, preclinical results do not guarantee safe and effective performance of product candidates in humans. The complexity of the human body cannot be perfectly, or sometimes, even adequately modeled by computer or cell culture systems or animal models. The length of time that it takes for us to complete clinical trials and obtain regulatory approval for product marketing has in the past varied and we expect similar variability in the future. Even when clinical trials are successful, regulatory authorities may question the sufficiency for approval of the trial endpoints we have selected. We develop product candidates internally and through licensing collaborations, partnerships and joint ventures. Product candidates that are derived from relationships may be subject to disputes between the parties or may prove to be not as effective or as safe as we may have believed at the time of entering into such relationship. Also, we or others could identify safety, side effects or manufacturing problems with our products, including our devices, after they are on the market.

Our results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments involving current and future products, sales growth of recently launched products, competition from other products including biosimilars, difficulties or delays in manufacturing our products and global economic conditions, including those resulting from geopolitical relations and government actions. In addition, sales of our products are affected by pricing pressure, political and public scrutiny and reimbursement policies imposed by third-party payers, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment. Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities. Our business may be impacted by government investigations, litigation and product liability claims. In addition, our business may be impacted by the adoption of new tax legislation or exposure to additional tax liabilities. Further, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors, or we may fail to prevail in present and future intellectual property litigation. We perform a substantial amount of our commercial manufacturing activities at a few key facilities, including in Puerto Rico, and also depend on third parties for a portion of our manufacturing activities, and limits on supply may constrain sales of certain of our current products and product candidate development. An outbreak of disease or similar public health threat, and the public and governmental effort to mitigate against the spread of such disease, could have a significant adverse effect on the supply of materials for our manufacturing activities, the distribution of our products, the commercialization of our product candidates, and our clinical trial operations, and any such events may have a material adverse effect on our product development, product sales, business and results of operations. We rely on collaborations with third parties for the development of some of our product candidates and for the commercialization and sales of some of our commercial products. In addition, we compete with other companies with respect to many of our marketed products as well as for the discovery and development of new products. Further, some raw materials, medical devices and component parts for our products are supplied by sole third-party suppliers. Certain of our distributors, customers and payers have substantial purchasing leverage in their dealings with us. The discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations. Our efforts to collaborate with or acquire other companies, products or technology, and to integrate the operations of companies or to support the products or technology we have acquired, may not be successful, and may result in unanticipated costs, delays or failures to realize the benefits of the transactions. A breakdown, cyberattack or information security breach of our information technology systems could compromise the confidentiality, integrity and availability of our systems and our data. Our stock price is volatile and may be affected by a number of events. Our business and operations may be negatively affected by the failure, or perceived failure, of achieving our sustainability objectives. The effects of global climate change and related natural disasters could negatively affect our business and operations. Global economic conditions may magnify certain risks that affect our business. Our business performance could affect or limit the ability of our Board of Directors to declare a dividend or our ability to pay a dividend or repurchase our common stock. We may not be able to access the capital and credit markets on terms that are favorable to us, or at all.

CONTACT: Amgen, Thousand Oaks  Madison Howard, 773-636-4910 (media)Elissa Snook, 609-251-1407 (media)Casey Capparelli, 805-447-1746 (investors)

REFERENCES

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/positive-chmp-opinion-supports-broader-use-of-amgens-repatha-before-a-first-heart-attack-or-stroke-302837810.html

—

immediapress/pr-newswire

NatGold Digital Launches Global Trading of NATG Through Multi-Channel Distribution Strategy

Immediapress — Wed, 29 Jul 2026 14:01:34 +0200

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE

CORAL GABLES, Fla., July 29, 2026 /PRNewswire/ — NatGold Digital Ltd. (“NatGold Digital” or the “Company”), a pioneering digital gold mining company with a patent-pending process for sustainably unlocking the intrinsic value of in-ground gold resources through its digital mining and blockchain-based tokenization platform, today announced the launch of global trading for the NatGold Token (NATG).

NATG is scheduled to commence trading on the MEXC Exchange Innovation Zone, a specialized trading area dedicated to emerging, high-potential, digital assets on one of the world’s largest, highest-volume cryptocurrency exchanges, at 11:00 a.m. (UTC) on Thursday, July 30, 2026, marking the activation of its multi-channel global distribution strategy: https://www.mexc.com/register

At the commencement of trading on MEXC, High Ridge Trust and 677 Financial Group will begin facilitating purchases through their respective onboarding and transaction channels. High Ridge Trust a U.S.-based qualified custodian, provides a dedicated onboarding and transaction pathway for eligible purchasers, with its primary focus on the United States. 677 Financial Group, a specialist in institutional digital asset transactions and onboarding, supports institutional participants, family offices, trusts and qualified purchasers globally. Each serve a distinct segment of the global marketplace and represent the first phase of NatGold Digital’s broader global distribution strategy, with additional organizations expected to be announced over coming weeks as worldwide availability of NATG continues to expand.

NATG is available through each of NatGold Digital’s distribution channels. Prospective purchasers can also visit the NATG Transaction Portal for guidance in accessing the appropriate purchase pathway.

NATG Transaction Portal: https://natgold.com/buy-sell-natg/

“Our integrated global distribution strategy provides immediate access to NATG through one of the world’s largest digital asset exchanges, complemented by dedicated participation pathways for U.S. purchasers, institutional and qualified participants globally,” said Andrés Fernández, Chief Executive Officer of NatGold Digital. “With our first NatGold Certified Resources successfully tokenized, these complementary distribution relationships establish a scalable foundation for expanding worldwide participation and long-term growth.”

The commercial launch follows the successful tokenization of NatGold Certified Resources from two qualifying gold properties, resulting in the minting of an aggregate 106,800 NATG pursuant to the Company’s NATG smart contracts and deployment on the Ethereum blockchain. The initial token supply was generated from the Cahuilla Gold Project Parcels 45 and 46 in California and the Alaska 4 patented mining claim at the Friday Gold Mine in Idaho. Together, these achievements represent the first commercial execution of NatGold Digital’s patent-pending digital mining model and the activation of the Company’s fully operational commercial ecosystem.

Supporting technical reports, NatGold Certified Resources Tokenization Certificates and blockchain verification associated with both tokenized resources are publicly accessible through the NATG smart contract, while the Company’s MiCA white paper is available on the NatGold Digital website, together reflecting NatGold Digital’s commitment to transparency, technical integrity regulatory transparency and responsible commercialization.

The NATG smart contract is publicly viewable on Etherscan at:

https://etherscan.io/address/0x59c323346F4f62aE18289F346501389392cf5939

“Our certification framework, governance standards, blockchain infrastructure, smart contracts and multi-channel global distribution strategy position NatGold for responsible long-term growth. As we continue expanding our global distribution network, we remain committed to maintaining the integrity that has guided the project from its inception,” said Mark Radke, Chairman of NatGold Digital.

Under the NatGold model, qualifying gold resources remain permanently undisturbed in Mother Nature’s Vault, while their intrinsic value is digitally represented through NATG. In accordance with NatGold’s established tokenization protocols, allocations from the initial tokenizations have also been made to the NatGold Contingency Fund and the NatGold Social Giveback Program.

With trading now underway, NatGold Digital will continue expanding both its portfolio of NatGold Certified Resources and its integrated global distribution strategy through additional strategic relationships that broaden worldwide participation in the NatGold ecosystem.

About NatGold Digital Ltd.NatGold Digital Ltd. is the global leader in digital gold mining and the architect and operator of a patent-pending, non-extractive platform designed to unlock the intrinsic value of technically verified in-ground gold resources that remain securely stored in Mother Nature’s Vault. NatGold Tokens are structured to represent standardized unit interests in NatGold Certified Resources, disclosed under internationally recognized geological Technical Reports — without physical extraction, processing, or movement of gold. The result is a superior fiat money alternative designed to help lead a global monetary reformation.

For additional background, please visit NatGold.com or our official YouTube channel for videos and information about our digital mining ecosystem: youtube.com/@NatGold_Digital.

ContactMedia@NatGold.comInvestorServices@NatGold.com+1 (646) 825-3038

The information presented in the above release has been compiled by NatGold with diligent effort to provide an accurate and realistic overview of the subject matter. Nonetheless, factors such as subjective judgment, reliance on circumstances beyond NatGold’s control, and external information sources inherently limit the exhaustiveness, completeness, and sufficiency of this information. Forward-looking statements are generally indicated by terms including “plans”, “expects”, “does not expect”, “is expected”, “scheduled”, “budget”, “estimates”, “projects”, “intends”, “anticipates”, “does not anticipate”, “believes”, and similar expressions, or by references to potential actions, events, or outcomes that “may”, “can”, “could”, “would”, “might”, or “will” transpire or be achieved. All forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially. Numerous risks, uncertainties, and events may result in outcomes that differ substantially from those described in NatGold’s forward-looking statements, including but not limited to: alterations in economic conditions or sector trends; fluctuations in currency and financial markets; volatility in gold prices and AISC costs; changes in investment activity; legal proceedings; legislative developments; as well as environmental, regulatory, political, judicial, and competitive circumstances in regions where NatGold operates. Additionally, technological, mechanical, and operational challenges may arise during NatGold’s development operations. Prospective NATG tokens purchasers are strongly advised to consult with a qualified financial advisor prior to purchasing NATG tokens and to use discretion in relation to decisions to purchase NATG tokens. References above to mineral resources being “certified” are specific to NatGold’s tokenization eligibility standards and do not signify compliance with the JORC Code, NI 43-101, or S-K 1300; such resources are instead certified under NatGold’s criteria as NatGold Certified Resources. While NatGold deems current assumptions reasonable based on available data, these assumptions may ultimately prove inaccurate. Actual outcomes could vary from forward-looking statements due to diverse risks, uncertainties, and unforeseen events. The information herein serves solely for general informational purposes and does not constitute an offer or solicitation for the purchase or sale of NatGold shares or securities or for the purchase or sale of any NATG tokens, nor is any information contained herein intended to be construed as making a recommendation, endorsement, or solicitation to engage in any investment strategy. NATG tokens are not intended to be “securities” in any jurisdiction, and NatGold makes no claim or representation related to the value of NatGold or NATG tokens. Forward-looking statements contained in this news release are current as of the date issued. Except where mandated by applicable securities laws, NatGold expressly disclaims any intent or obligation to update or revise any forward-looking statements in response to new data, future developments, or otherwise. Furthermore, the Company assumes no commitment to address third-party expectations or statements regarding issues discussed in this document. Investing in early-stage digital assets entails considerable risk. Any such investment is speculative and involves a high degree of risk, including but not limited to loss of capital. An investment in the NATG tokens, or any other digital asset, may not be appropriate for everyone, and you should carefully consider the appropriate risks, your financial situation, risk tolerance, and investment goals before making any investment decisions. As a digital asset, NATG tokens are also subject to inherent risks related to blockchain technology, including but not limited to, regulatory uncertainty, market adoption, manipulation, volatility, and cyber security risks. Access to NATG trading will be available only to eligible participants in supported jurisdictions, with each participant subject to applicable jurisdictional eligibility, onboarding, regulatory, geographic, and platform requirements. Prospective purchasers should conduct their own due diligence and should consult with their respective financial, legal, tax, and/or other professional advisors.

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/natgold-digital-launches-global-trading-of-natg-through-multi-channel-distribution-strategy-302837288.html

—

immediapress/pr-newswire

Piping System: un futuro d’acciaio

Immediapress — Wed, 29 Jul 2026 12:51:24 +0200

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE

La storia della Piping System inizia con una valigia, quella con cui Alfonso Alterino lasciò la Calabria per trasferirsi a Parma, seguendo la donna che sarebbe diventata sua moglie. Una scelta dettata dall’amore e accompagnata da poche certezze, ma da un’idea molto precisa: imparare, costruire, non considerare mai un traguardo come definitivo. Dopo un lungo percorso maturato nel tessuto produttivo del territorio e numerose esperienze in ruoli di crescente responsabilità, nel 2014 prende forma l’iniziativa che cambierà la sua vita professionale: nasce Piping System. L’azienda muove i primi passi come realtà artigiana, specializzata in saldatura e piping industriale. Fin dall’inizio, però, l’obiettivo va oltre la semplice erogazione di un servizio: la volontà è costruire un’impresa capace di crescere nel tempo, che sappia investire nelle persone, nelle competenze e nell’innovazione. Grazie a una visione strategica, a investimenti continui e a un costante sviluppo del know-how aziendale, Piping System amplia progressivamente il proprio raggio d’azione, trasformandosi in una realtà strutturata e multiservizio, oggi punto di riferimento nel settore impiantistico-industriale.

“Oggi Piping System è un’organizzazione industriale con tre stabilimenti produttivi a Parma, oltre 9.800 metri quadrati di aree coperte e circa 130 persone tra dipendenti e collaboratori esterni”, racconta Alterino. “Il fatturato 2025 è di 10 milioni di euro. Numeri che raccontano una crescita, ma non ne spiegano da soli la direzione. La nostra scelta è stata quella di passare dal singolo intervento alla presa in carico dell’intero progetto. Non vogliamo essere soltanto fornitori, ma partner affidabili e capaci di affiancare il cliente dalla richiesta iniziale alla messa in esercizio”.

Il perimetro operativo è ampio: analisi e progettazione CAD 2D e 3D, software e automazione, carpenteria inox, prefabbricazione di linee di piping, saldatura TIG e orbitale, costruzione di skid di processo, serbatoi e macchine, assemblaggio, collaudo, installazione e manutenzione. In un settore dove le interfacce sono spesso una fonte di ritardi e complessità, Piping System punta al modello one-stop supplier: un interlocutore unico in grado di coordinare lavorazioni meccaniche, elettriche e di processo, documentazione tecnica e validazione.

“La sfida non è produrre di più, ma produrre meglio per proiettarsi nel futuro”, spiega il CEO. “Per questo l’azienda ha fatto della qualità e dell’affidabilità un elemento strutturale: saldatori qualificati, procedure certificate, una solida collaborazione con l’Istituto Italiano della Saldatura, controlli boroscopici e dimensionali costanti, tracciabilità dei materiali e welding book per ogni commessa. Accanto alla certificazione UNI EN ISO 9001, il sistema di gestione comprende la UNI EN ISO 14001 per l’ambiente e la UNI EN ISO 45001 per salute e sicurezza, oltre alle qualifiche richieste per saldatura, carpenteria e attrezzature a pressione. È un patrimonio tecnico che consente all’azienda di operare per alcuni dei più importanti gruppi nazionali e internazionali nei settori food & beverage, farmaceutico, chimico ed energetico, nel pieno rispetto dei rigorosi requisiti di riservatezza richiesti da questi comparti.”

Proprio negli ultimi anni il settore farmaceutico è diventato uno dei fronti di maggiore specializzazione, insieme alla microelettronica. Per l’industria Piping System realizza, tra le altre cose, linee ASME/BPE, sistemi per acqua purificata e Water for Injection, distribuzione di vapore puro, aria compressa sterile, azoto di processo e impianti CIP/SIP. Ambiti nei quali l’acciaio inox è solo il punto di partenza: contano l’esecuzione controllata e documentata delle saldature, la validazione GMP, la documentazione e la capacità di garantire che ogni singolo componente sia rintracciabile. Nella microelettronica, invece, precisione, affidabilità e stabilità dimensionale diventano requisiti essenziali per strutture e componenti destinati a processi ad alto contenuto tecnologico.

Alla base della traiettoria imboccata dall’impresa c’è un investimento continuo in formazione, macchinari, digitalizzazione e ricerca applicata. Dalle saldatrici orbitali alle macchine T-Drill, dai sistemi di taglio tubo laser al controllo tridimensionale CMM, la tecnologia è letta come leva per anticipare i problemi, contenere i tempi e aumentare le performance. “Il mondo del lavoro è estremamente dinamico”, dichiara Alterino. “Le intuizioni di ieri sono la realtà di oggi, ma probabilmente domani non basteranno. E per un’azienda che vuole mantenere un ruolo di leader nel mercato e di punto di riferimento per tutto il settore è importantissimo stare sempre un passo avanti. Perché anticipare il mercato è solo il punto di partenza. È fondamentale credere nel valore delle persone. Squadre tecniche, responsabili di cantiere e project manager devono lavorare in modo integrato, con piattaforme condivise per monitorare commesse, materiali e avanzamento produttivo. Per questo, Piping System investe in personale altamente qualificato”.

Il prossimo passo è rendere l’integrazione tra persone e tecnologia ancora più profonda. Piping System guarda a nuove competenze produttive e tecnologiche da internalizzare, così da completare dentro i propri stabilimenti un numero crescente di lavorazioni oggi affidate all’esterno. L’obiettivo è un ciclo produttivo sempre più autonomo, capace di controllare tempi, qualità e capacità di risposta. “Il nostro logo è un ingranaggio”, conclude Alterino. “A prima vista può sembrare un semplice componente, un piccolo elemento nell’immensità di un sistema. Eppure è proprio in quella apparente semplicità che risiede il suo significato più profondo. Ogni ingranaggio è composto da una moltitudine di elementi ancora più piccoli, ciascuno indispensabile. Solo quando ogni singolo componente trova il proprio posto e si integra perfettamente con gli altri, il meccanismo prende vita e funziona con precisione, armonia ed efficienza. Io credo profondamente che il valore di un’organizzazione non si misuri dalla grandezza dei suoi singoli elementi, ma dalla loro capacità di collaborare, completarsi e muoversi nella stessa direzione. Perché è solo quando ogni tassello svolge il proprio ruolo con competenza e responsabilità che il sistema raggiunge la sua massima espressione”.

www.pipingsystemsrl.it

Contatti:
Prima Pagina Italia
primapaginaitalia@libero.it

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE

Responsabilità editoriale di Prima Pagina Italia

—

immediapress

Allarme depurazione sulle coste toscane: foci inquinate e cartelli assenti nel mirino di Goletta Verde

REDAZIONE — Wed, 29 Jul 2026 12:14:03 +0200

Metà dei punti monitorati lungo le coste toscane presenta livelli di inquinamento oltre i limiti di legge. È questo il bilancio tracciato dalla quarantesima edizione di Goletta Verde, la storica campagna estiva promossa da Legambiente per la difesa del mare e del litorale. I campionamenti, effettuati dai volontari tra il 6 e l’8 luglio, si sono concentrati su 20 punti specifici, di cui 15 presso le foci dei fiumi e 5 a mare. Le analisi microbiologiche hanno evidenziato criticità legate a concentrazioni elevate di Escherichia coli ed Enterococchi intestinali in dieci aree, individuando nel 20% dei casi siti inquinati e nel 30% fortemente inquinati. Otto dei dieci punti critici corrispondono a sbocchi fluviali.

Il quadro regionale presenta marcate disomogeneità. Nella provincia di Grosseto, su sei prelievi, tre risultano entro i limiti (fiume Bruna, fiume Albegna e Cala Galera), mentre sono emersi superamenti alla foce del fiume Osa e valori da fortemente inquinato per il fiume Gora a Follonica e il fosso della Tagliata Etrusca ad Ansedonia. In provincia di Livorno, comprendente l’Isola d’Elba, quattro punti su sei rientrano nei parametri di legge; le eccezioni negative riguardano lo scarico di Salivoli, giudicato fortemente inquinato, e il porto di Marciana Marina. Situazione tesa in provincia di Lucca, con entrambi i siti monitorati oltre i limiti: il fosso Fiumetto è risultato fortemente inquinato e il fosso Abate inquinato. A Massa-Carrara, la foce del fiume Versilia è a norma, a differenza dei torrenti Lavello e Brugiano, fortemente inquinati, e del Carrione, inquinato. Risultati interamente positivi per la provincia di Pisa, dove sia la foce dell’Arno che quella del canale Scolmatore rientrano nei limiti.

Accanto ai dati sulla qualità dell’acqua, l’indagine ha rilevato una forte carenza nell’informazione fornita ai bagnanti. Nell’85% dei punti di prelievo mancano i cartelli informativi sulla qualità delle acque, presenti fisicamente solo in tre località. Nei pressi delle foci fluviali, aree per legge non idonee ai tuffi, nel 60% dei casi i tecnici non hanno trovato gli appositi avvisi di divieto di balneazione, la cui installazione spetta alle amministrazioni locali.

I vertici di Legambiente Toscana, Fausto Ferruzza e Federico Gasperini, hanno evidenziato la persistenza di problemi nel sistema depurativo, pur notando alcune schiarite: “Rispetto allo scorso anno abbiamo rilevato lievi miglioramenti per la qualità delle acque dei fiumi che si riversano nelle zone costiere della Toscana: nell’area nord il miglioramento ha riguardato in particolare la foce del fiume Versilia. Va meglio anche l’Elba. Invece rimangono stabili alcune criticità alle foci dei fiumi nella parte centrale e sud della Toscana”.

Marco Mancini, dell’ufficio scientifico nazionale dell’associazione, ha ribadito la necessità di intervenire sulle reti fognarie: “Le foci dei fiumi non sono balneabili per legge, ma spesso durante i nostri prelievi vediamo cittadini e cittadine che fanno il bagno nelle zone limitrofe. Per questo i cartelli di divieto di balneazione quelli sulla qualità delle acque diventano fondamentali: la cittadinanza ha diritto di usufruire del mare in maniera sicura e consapevole”.

L’iniziativa itinerante è sostenuta dai consorzi CONOU e CONOE, realtà impegnate nel settore dell’economia circolare. Alessia Merlo, responsabile per il CONOU, ha sottolineato il ruolo dell’educazione per formare cittadini attenti alla sostenibilità. Tommaso Campanile, presidente del CONOE, ha ricordato l’impatto del recupero degli scarti: nell’ultimo anno, nella sola Toscana, il sistema consortile ha raccolto circa 7.000 tonnellate di olio alimentare esausto, evitandone la dispersione in mare.

Il viaggio dell’imbarcazione prevede ora due tappe alla Marina di Punta Ala. Giovedì 30 luglio, a partire dalle 17,00, si terranno laboratori per bambini e un seminario sul turismo sostenibile nell’ambito delle iniziative di Festambiente. Venerdì 31 luglio, alle 11,00 e alle 17,00, andranno in scena ulteriori percorsi didattici e un dibattito pubblico focalizzato sulla tutela della biodiversità.

REDAZIONE

Lockton Launches Global Data Centers & Digital Infrastructure Practice

Immediapress — Wed, 29 Jul 2026 12:01:05 +0200

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE

Advisory practice delivers integrated risk solutions for the infrastructure powering AI, cloud computing, and digital connectivity

KANSAS CITY, Mo., July 29, 2026 /PRNewswire/ — Lockton, the world’s largest privately held, independent insurance brokerage, today launched its global Data Centers & Digital Infrastructure Practice, a consultative practice helping organizations navigate the complex risks associated with the infrastructure that stores, processes, and moves information around the world. The specialty practice builds upon Lockton’s extensive experience supporting complex digital infrastructure risks globally, including hyperscale campuses, multi-building developments, phased construction programs, operational portfolios, and power-related infrastructure.

“Data centers are at the core of how the modern world operates, and the risk landscape behind that infrastructure has become increasingly interconnected, capital-intensive, and time-sensitive,” said Tim Ryan, Lockton’s U.S. President. “Organizations need advisors who understand the full lifecycle from planning and site selection through ongoing operations and scale. Our practice is built to advise clients so they can navigate that complexity with confidence.”

The practice combines risk strategy, analytics, engineering insight, and market expertise into a single advisory model and serves the full ecosystem, including owners, operators, developers, investors, hyperscalers, and technology providers. The team supports clients from project planning – where foundational risk decisions are made – through construction, operational launch, portfolio expansion, and ongoing risk management.

While solutions will be customized for each client’s needs, the new practice provides a suite of innovative products and proprietary solutions spanning construction and property risk, errors and omissions, service level agreements, environmental risk, cyber, surety and more.

“The global data center and digital infrastructure market is evolving at extraordinary speed,” said Chris Brown, CEO of Lockton International. “Lockton’s independent model allows us to bring together global expertise from regions around the world, tailor solutions around each client’s business, and deliver advice that extends well beyond traditional insurance placement.”

The Data Centers & Digital Infrastructure Practice will be led by James Nelson in the United States and Sam Baker in the United Kingdom. Both will partner with Lockton leaders across the globe to drive the overarching strategy. Nelson brings deep experience in risk advisory, consulting, and insurance. Most recently, he served as global head of client engagement at Eldin Risk, and he previously held roles at Marsh, Cerberus Capital, and Alvarez & Marsal, where he advised clients on complex risk strategies. Baker has been at Lockton for 13 years advising on innovative insurance solutions for clients throughout the world. For the past few years, he has been at the forefront of the creation of Lockton’s proprietary product offerings for Data Centers.

“Our role is helping clients build and operate critical infrastructure, from project to portfolio, with greater resilience, certainty, and confidence,” Ryan said. “When risk is managed proactively, organizations can spend less time navigating complexity and more time focused on growth and innovation.”

Learn more about Lockton’s Data Centers & Digital Infrastructure Practice.

About Lockton

What makes Lockton stand apart is also what makes us better: independence. Lockton’s private ownership empowers its nearly 15,000 Associates doing business in more than 180 countries to focus solely on clients’ risk and insurance needs. With expertise that reaches around the globe, Lockton delivers the deep understanding needed to accomplish remarkable results. For more information, visit www.lockton.com
.

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/lockton-launches-global-data-centers–digital-infrastructure-practice-302837352.html

—

immediapress/pr-newswire

Mars strengthens its European mint supply chain through the Shubh Mint programme

Immediapress — Wed, 29 Jul 2026 11:35:59 +0200

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE

LONDON, July 29, 2026 /PRNewswire/ — Mars is bringing natural menthol sourced through its Shubh Mint programme into its European chewing gum supply chain, as the company begins integrating the sustainably sourced ingredient into its manufacturing operations in the UK and Poland.

Mint is a critical ingredient for many of Mars, Incorporated’s global brands, yet its supply chain presented significant business risk. Approximately 80% of the world’s natural menthol originates from a single region: Uttar Pradesh, India, creating a highly concentrated supply chain vulnerable to climate impacts, declining yields and rising production costs. While synthetic menthol is readily available and widely used in the industry, Mars chose to invest in the future of natural mint, recognising that building a more resilient agricultural system could deliver long-term benefits for both the business and the thousands of farmers who depend on the crop.

Growing impact from pilot to partnership

In 2017, Mars launched the Shubh Mint programme in partnership with implementation expert Tanager. Designed as a long-term initiative, the programme aims to strengthen natural mint production by improving farming practices, increasing resilience to climate change and supporting more sustainable livelihoods across mint-growing communities.

The programme began with a two-year research and pilot phase to better understand the root causes affecting productivity and farmer incomes. Climate-smart agricultural practices and improved planting materials were trialled on quarter-acre demonstration plots with volunteer farmers, enabling peer-to-peer learning, reducing the risks associated with adopting new techniques and building confidence before expanding the programme at scale.

“Before the programme started, many mint farming households were struggling to remain profitable. Through Mars’ investment, farmers now have access to the knowledge, practices and inputs that have significantly improved their profitability. You can really see the difference in how the programme has impacted these mint farming communities,” says Joseph Boulier, Managing Director, Food Systems, Tanager.

Creating shared value: People, planet, performance

The programme was designed around the belief that long-term business growth is built by investing in resilient communities and healthy ecosystems. The success of these demonstration plots created a groundswell of interest. The programme then scaled from a pilot to a full-scale community-wide ecosystem initiative – expanding farmer participation, building supply systems through Farmer Producer Companies, and unlocking opportunities for women via Self-Help Groups. That turned individual gains into community-wide resilience. The results of this integrated approach are clear:

“The most meaningful impact of Shubh is seeing women who once identified themselves with a thumbprint now proudly signing their own names. That simple change reflects something far greater: confidence, agency and the belief that they can shape their own futures. When women thrive, the impact extends far beyond them, strengthening families, inspiring communities and creating opportunities for the next generation,” said Meenal Bahirwani, Sustainable Sourcing Lead, Mars Snacking.

The new standard for resource saving and responsible supply chains

The ambition for the Shubh Mint programme continues to expand. Building on the programme’s success, Mars is now evolving Shubh Mint towards a ‘full farm’ approach, helping support more farmers to achieve a verified living income. By applying climate-smart practices across all crops, rather than mint alone, the programme aims to build year-round profitability, diversify household incomes and strengthen resilience to single-crop risks, creating true economic resilience for families and communities.

“What began as a response to a single, vulnerable ingredient has become a long-term commitment and a replicable blueprint for transforming agricultural systems and empowering communities. The Mars Shubh Mint programme shows how sustainability and business performance go hand in hand. By investing in livelihoods and reducing environmental impact, we can build a more resilient and efficient supply chain,” says Sam de Frates, VP Commercial and Sustainability, Mars Snacking Europe and Central Eurasia.

Through this model, Mars is creating a new standard for supply chains – one where value is shared, communities are empowered, ecosystems are restored, and business performance is a direct result of that investment.

Notes to editors

ABOUT MARS, INCORPORATED

Mars, Incorporated is driven by the belief that the world we want tomorrow starts with how we do business today. Based on combined Mars and Kellanova 2025 net sales, we are now a $65bn+ family-owned business, with a diverse portfolio of quality snacking and food products that delight millions of people every day, and leading pet care products and veterinary services that support pets all around the world. We produce some of the world’s best-loved brands including ROYAL CANIN®, PEDIGREE®, WHISKAS®, CESAR®, M&M’S®, SNICKERS®, EXTRA®, Pringles®, Cheez-It®, and BEN’S ORIGINAL™. Our international networks of pet hospitals, including BANFIELD™, BLUEPEARL™, VCA™ and ANICURA™ span preventive, general, specialty, and emergency veterinary care, and our global veterinary diagnostics business ANTECH® offers breakthrough capabilities in pet diagnostics. The Mars Five Principles — Quality, Responsibility, Mutuality, Efficiency and Freedom — inspire our approximately 170,000 Associates to act every day to help create a better world for people, pets and the planet.

For more information about Mars, please visit www.mars.com.

Join us on Facebook, Instagram, LinkedIn and YouTube.

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/mars-strengthens-its-european-mint-supply-chain-through-the-shubh-mint-programme-302837617.html

—

immediapress/pr-newswire

Sorona® and WGSN Announce Top Bio-Based Material Trends of 2027

Immediapress — Wed, 29 Jul 2026 10:13:38 +0200

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE

Bio-based materials emerge as a leading trend shaping the future of fashion across athleisure and luxury ready-to-wear apparel

NEWARK, Del., July 29, 2026 /PRNewswire/ — Sorona®, the partially bio-based polymer from Covation Biomaterials (CovationBio™), and global trend forecasting authority WGSN today release the material trends shaping the textile industry through 2027 and beyond following a comprehensive examination of bio-based functional fiber applications and global data.

Highlights

These findings arrive at a pivotal moment as global fashion brands navigate the pressures of shifting supply chains paired with evolving consumer expectations. The global biomaterials market is projected to reach USD 285.3 billion by 2029, growing at a compound annual rate of 14.5%, a pace that significantly outstrips conventional textile and synthetic fiber sectors. Consumer search data tells the same story: searches for “natural fibers” have surged, with wool base layer terms rising 61% and cotton leggings 21% year-over-year. Interest in “chemical-free materials” is trending upward globally with no signs of slowing.

The three major trends expected to influence apparel development:

New Nature, which explores circular, bio-based, and hybrid fiber combinations built around a new understanding of natural materials;

Climate Flex, which addresses the growing demand for temperature-regulating, performance-ready fabrics in a changing climate

Sensory Empowerment, reflecting consumer priorities around skin-safe, tactile, wellness-forward textiles.

Across all three trends, Sorona® provides commercially available solutions that help brands combine bio-based content with the high-performance attributes consumers expect including stretch recovery, wrinkle resistance, breathability, durability, and comfort. Partially made with renewable plant-based ingredients, Sorona® can be blended with natural or cellulosic fibers to address the inherent performance limitations of those fibers while preserving their natural texture and feel.

Through its established Common Thread Fabric Certification Program, and 25-year history collaborating with an ecosystem of mills, brands, and designers, Sorona® has built a modern model for how apparel designers source performance stretch fabrics, restorative comfort knits, and woven textiles for luxury casualwear, ready-to-wear, athleisure, smart sportswear, and uniforms.

About Sorona®Sorona® is an innovative, 37% bio-based polymer delivering a unique combination of comfort and high-performance for over 25-years. Its inherent softness, stretch recovery, breathability, and wrinkle resistance help create fabrics that look better, feel better, and last longer. As a filament or staple fiber, Sorona® blends effortlessly with natural and cellulosic fibers such as wool, cotton, and linen, bringing enhanced performance to athleisure, activewear, casualwear, and ready-to-wear apparel. For more information, visit Sorona.com and follow @soronafiber on Instagram.

About CovationBioFounded in 2022 in Newark, Delaware, Covation Biomaterials LLC is a leading global innovator of commercially available high-performance, sustainable solutions for the apparel and homegoods industries. The company’s legacy of groundbreaking scientific innovation began with the commercialization of Sorona® polymer 25 years ago, and continues today with the promise to deliver novel biomaterials at scale across multiple industries including its latest innovation bioPTMEG, with plans for commercialization in 2026. For more information, visit CovationBio.com and follow on LinkedIn.

About WGSNWGSN is the world’s leading trend forecaster, with 28 years of expertise spanning 38 cities across six continents. Using its proprietary methodology, WGSN transforms macro trend analysis into actionable, consumer-centric strategies for brands and manufacturers worldwide. Visit wgsn.com for more information.

Media Contact: Heather Barbod, heather@inspireelemental.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/sorona-and-wgsn-announce-top-bio-based-material-trends-of-2027-302835784.html

—

immediapress/pr-newswire

METLEN Signs Landmark Gallium Supply Agreement

Immediapress — Wed, 29 Jul 2026 10:02:34 +0200

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 (“EU MAR”) AND ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF DOMESTIC LAW IN THE UNITED KINGDOM (THE “UK”) BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (“UK MAR”)

Major Milestone for Europe’s Critical Raw Materials Strategy

ATHENS and LONDON, July 29, 2026 /PRNewswire/ — METLEN announces a long-term commercial agreement for the supply of approximately 25% of the annual gallium production from its planned production facility in Greece. The terms of the agreement are confidential.

The agreement marks the first major commercial gallium supply agreement between a European producer and a leading US technology company and constitutes a strategic milestone for Europe’s efforts to strengthen the resilience of its critical raw materials supply chain.

Gallium is a critical raw material essential for AI technology, advanced renewables infrastructure, telecommunications, and defence solutions. Today, global gallium production is overwhelmingly concentrated, making the development of alternative and reliable supply sources strategically important for all industrial economies.

METLEN is the first company in Europe to establish integrated gallium production and the first to secure a commercial agreement for European-produced gallium, positioning Greece and Europe at the forefront of a new strategic industrial value chain.

The achievement is the result of the long-standing research and innovation efforts of the company’s in-house R&D teams, located in the historic Aluminium of Greece industrial plant, alongside the newly established Critical & Rare Metals sub-sector of M Metals.

Evangelos Mytilineos, Executive Chairman of METLEN commented on the agreement, “We are particularly proud that METLEN is pioneering a completely new industrial chapter for both Greece and Europe; the successful development of gallium production carried out by our teams at Aluminium of Greece. For the first time in METLEN’s history, one of our metallurgical products has attracted such strong interest from leading industrial economies worldwide. This reflects both the strategic importance of gallium and the confidence of global technology leaders in the quality and reliability of our material, which has already undergone extensive qualification testing.”

METLEN’s flagship investment for gallium production was officially recognized by the European Commission as a Strategic Project under the Critical Raw Materials Act (CRMA). The strategic importance of the project has also been recognized by the European Investment Bank (EIB), which approved financing under the REPowerEU framework.

About METLEN

METLEN Energy & Metals Plc (METLEN) is an international industrial and energy company, holding a leading position in the metals and energy sectors, focused on sustainable growth and the circular economy. METLEN has established itself as a benchmark in competitive “green” metallurgy at both European and global level, operating the only fully integrated bauxite, alumina and primary aluminium production unit in the European Union, with privately owned port facilities. In the Energy Sector, METLEN provides integrated energy solutions through the implementation of thermal and renewable power generation projects, electricity distribution and trading, as well as investments in network infrastructure, battery storage and other green technologies. METLEN operates across five continents and in more than 40 countries, employing over 8,500 people worldwide and implementing a fully synergistic model across its Sectors.

METLEN Financial Highlights

METLEN has its primary listing on the London Stock Exchange and secondary listed on the Athens Stock Exchange and is a constituent of the FTSE 100 Index. In 2025, METLEN reported consolidated revenue of €7.11 billion and EBITDA of €753 million with net profit of €314 million. Adjusted net debt stood at €2.10 billion, with a Net Debt/EBITDA ratio of 3.1x, reflecting strong financial resilience. METLEN is rated by leading international sustainability and ESG agencies, holding the unique Greek position in the Dow Jones Best-in-Class Emerging Market Index, and distinguished across MSCI, Sustainalytics, ISS Quality score, ISS Corporate Score, S&P Global ESG, LSEG, CDP, FTSE Russell, ESG Book, EcoVadis, Bloomberg and IdealRatings.

www.metlen.com | Facebook | X | YouTube | LinkedIn

Important Notices

The person responsible for arranging the release of this announcement on behalf of Metlen Energy & Metals PLC is Leda Condoyanni, Company Secretary.

LEI number: 213800ZSR3HVKMMPVG86

This announcement contains inside information for the purposes of UK MAR and EU MAR.

This announcement contains statements which are or may be deemed to be ‘forward-looking statements’. Forward-looking statements involve risks and uncertainties because they relate to events and depend on events or circumstances that may or may not occur in the future. All forward-looking statements in this announcement reflect METLEN’s present view with respect to future events as at the date of this announcement. Forward-looking statements are not guarantees of future performance and actual results in future periods may and often do differ materially from those expressed in forward-looking statements. Except where required by law or regulation, METLEN undertakes no obligation to release publicly the results of any revisions to any forward-looking statements in this announcement that may occur due to any change in its expectations or to reflect any events or circumstances arising after the date of this announcement.

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/metlen-signs-landmark-gallium-supply-agreement-302837536.html

—

immediapress/pr-newswire

FORD NOMINA MARIA GRAZIA DAVINO VICEPRESIDENTE DELLE VENDITE DI FORD OF EUROPE

Immediapress — Wed, 29 Jul 2026 10:01:32 +0200

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE

COLONIA, Germania, 29 luglio 2026 /PRNewswire/ — Ford continua a rafforzare il proprio team dirigenziale in Europa, accelerando la trasformazione della propria attività e concentrandosi maggiormente nell’offrire un’esperienza esclusiva ai clienti di tutta la regione.

L’azienda ha annunciato oggi che Maria Grazia Davino è stata nominata vicepresidente delle vendite di Ford of Europe, con effetto dal 1° ottobre 2026. Davino sarà responsabile della gestione delle vendite in tutta Europa e della supervisione di tutte le operazioni commerciali, tra cui la vendita al dettaglio, la rete di concessionari e la distribuzione. Il referente diretto sarà Jim Baumbick, presidente di Ford of Europe.

La nomina di Davino riflette l’impegno di Ford nell’offrire ai clienti in Europa una gamma di prodotti altamente differenziata e personalizzata in base alle esigenze della clientela del territorio europeo. La strategia di Ford per l’Europa consiste nel rafforzare Ford Pro, il settore dei veicoli commerciali dell’azienda, dove Ford detiene attualmente una posizione di leadership in Europa, e nel lanciare un’offensiva di prodotti nel segmento dei veicoli passeggeri con cinque nuovi modelli che saranno disponibili negli showroom entro il 2029.

Davino è una dirigente di grande esperienza con oltre 20 anni di carriera nel settore automobilistico, specializzata in vendite, marketing e trasformazione aziendale. Di recente ha ricoperto il ruolo di Amministratrice Delegata Regionale di BYD Europe, guidando le operazioni in Germania, Austria, Svizzera, Polonia, Ungheria, Repubblica Ceca, Slovacchia e nei Paesi nordici, contribuendo con successo allo sviluppo del marchio in ciascun mercato.

Prima di entrare in BYD, Davino ha ricoperto per oltre un decennio ruoli dirigenziali di alto livello presso Stellantis. Infine, è stata Amministratrice Delegata del gruppo e CEO di Stellantis UK, gestendo un portafoglio complesso e guidando la transizione dell’azienda verso i veicoli elettrici. All’inizio della sua carriera in Stellantis, ha ricoperto posizioni dirigenziali con responsabilità nelle vendite e nel marketing europei, gestendo le attività in Svizzera, Austria, Germania e Regno Unito. Ha iniziato la sua carriera presso Lamborghini Automotive nel 2003.

“Maria Grazia è una leader di grande esperienza, con una profonda conoscenza del panorama automobilistico europeo”, ha affermato Jim Baumbick, presidente di Ford of Europe. “La sua comprovata competenza nella costituzione di team altamente performanti e nella gestione di solide relazioni con i clienti e i concessionari sarà preziosa per la nostra costante crescita in Europa”.

Davino opererà nella sede di Colonia.

Informazioni su Ford Motor Company

Ford Motor Company (NYSE: F) è un’azienda globale con sede a Dearborn, Michigan, che punta alla costruzione di un mondo migliore, in cui ogni persona sia libera di muoversi e perseguire i propri sogni. Il piano Ford+ dell’azienda, finalizzato alla crescita e alla creazione di valore, combina punti di forza esistenti, nuove capacità e relazioni costanti con i clienti per arricchire le loro esperienze e rafforzarne la fidelizzazione. Ford sviluppa e realizza autocarri, SUV, furgoni commerciali e autovetture innovativi ed esclusivi, nonché veicoli di lusso Lincoln, offrendo al contempo servizi connessi, tra cui BlueCruise (ADAS) e soluzioni di sicurezza. L’azienda offre libertà di scelta attraverso tre segmenti di attività orientati al cliente: Ford Blue, che progetta veicoli a benzina e ibridi iconici; Ford Model, che sviluppa veicoli elettrici all’avanguardia insieme a software integrati che garantiscono esperienze digitali sempre attive per tutti i clienti; e Ford Pro, che aiuta i clienti commerciali a trasformare e ampliare le proprie attività con veicoli e servizi su misura per le loro esigenze. Inoltre, l’azienda fornisce servizi finanziari tramite Ford Motor Credit Company. Ford vanta circa 168.000 dipendenti in tutto il mondo. Per maggiori informazioni sull’azienda e sui prodotti e i servizi offerti, visitare corporate.ford.com.

Per i comunicati stampa Ford, il materiale informativo, foto e video, visitare From the Road, www.fordmedia.eu o www.media.ford.com. Seguiteci su www.linkedin.com/company/ford-in-europe, www.youtube.com/FordNewsEurope, www.instagram.com/FordNewsEurope, www.threads.net/@fordnewseurope and www.tiktok.com/@FordNewsEurope

View original content to download multimedia:https://www.prnewswire.com/it/comunicati-stampa/ford-nomina-maria-grazia-davino-vicepresidente-delle-vendite-di-ford-of-europe-302837061.html

—

immediapress/pr-newswire

FORD NAMES MARIA GRAZIA DAVINO VICE PRESIDENT, SALES, FORD OF EUROPE

Immediapress — Wed, 29 Jul 2026 10:01:32 +0200

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE

COLOGNE, Germany, July 29, 2026 /PRNewswire/ — Ford is continuing to strengthen its leadership team in Europe as it accelerates the transformation of its business and sharpens its focus on delivering an exceptional experience for customers across the region.

The company today announced that Maria Grazia Davino has been appointed vice president, sales, Ford of Europe, effective October 1, 2026. Davino will be responsible for leading sales across Europe and overseeing all commercial operations, including retail, dealer network and distribution. She will report directly to Jim Baumbick, President, Ford of Europe.

Davino’s appointment reflects Ford’s commitment to serving customers in Europe with a product portfolio that is highly differentiated and tailored to the needs of European customers. Ford’s strategy for Europe is to strengthen Ford Pro, the company’s commercial vehicle business where Ford currently holds a leadership position in Europe, and to unleash a product offensive in the passenger vehicle segment with five new models arriving in showrooms by 2029.

Davino is an accomplished senior executive with over 20 years of experience in the automotive industry, specializing in sales, marketing and business transformation. She most recently served as Regional Managing Director of BYD Europe, leading operations across Germany, Austria, Switzerland, Poland, Hungary, the Czech Republic, Slovakia and the Nordic countries, and successfully developing the brand in each market.”

Before joining BYD, Davino spent more than a decade, in senior leadership roles at Stellantis. Most recently, she was Group Managing Director and CEO for Stellantis UK, managing a complex portfolio and leading the business’s transition to electric vehicles. Earlier in her Stellantis career, she held leadership positions responsible for European Sales and Marketing and running the businesses in Switzerland, Austria, Germany and the UK. She began her career at Lamborghini Automotive in 2003.

“Maria Grazia is a highly accomplished leader with deep expertise across the European automotive landscape,” said Jim Baumbick, president, Ford of Europe. “Her track record of building high-performing teams and building strong customer and dealer relationships will be invaluable as we continue to grow our business in Europe.”

Davino will be based in Cologne.

About Ford Motor Company

Ford Motor Company (NYSE: F) is a global company based in Dearborn, Michigan, committed to helping build a better world, where every person is free to move and pursue their dreams. The company’s Ford+ plan for growth and value creation combines existing strengths, new capabilities, and always-on relationships with customers to enrich experiences for customers and deepen their loyalty. Ford develops and delivers innovative, must-have Ford trucks, sport utility vehicles, commercial vans and cars and Lincoln luxury vehicles, along with connected services, including BlueCruise (ADAS) and security. The company offers freedom of choice through three customer-centered business segments: Ford Blue, engineering iconic gas-powered and hybrid vehicles; Ford Model e, inventing breakthrough electric vehicles (“EVs”) along with embedded software that defines always-on digital experiences for all customers; and Ford Pro, helping commercial customers transform and expand their businesses with vehicles and services tailored to their needs. Additionally, the company provides financial services through Ford Motor Credit Company. Ford employs about 168,000 people worldwide. More information about the company and its products and services is available at corporate.ford.com.

Ford news releases, related materials, photos and video, visit From the Road, www.fordmedia.eu or www.media.ford.com. Follow www.linkedin.com/company/ford-in-europe, www.youtube.com/FordNewsEurope, www.instagram.com/FordNewsEurope, www.threads.net/@fordnewseurope and www.tiktok.com/@FordNewsEurope

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/ford-names-maria-grazia-davino-vice-president-sales-ford-of-europe-302836807.html

—

immediapress/pr-newswire